Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension

British Journal of Nutrition

Volumn 94, Issue 1, 2005, Pages 84-91

  Mizuno, Seiichi ^a   Matsuura, Keiichi ^a   Gotou, Takanobu ^a   Nishimura, Shingo ^a   Kajimoto, Osami ^b   Yabune, Mitsuharu ^b   Kajimoto, Yoshitaka ^b   Yamamoto, Naoyuki ^a  

^a CALPIS Co Ltd   (Japan)

^b Soiken Inc   (Japan)

Author keywords

Antihypertensive effect; Casein hydrolysate; Clinical study; VPP and IPP

Indexed keywords

CASEIN HYDROLYSATE; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASPERGILLUS ORYZAE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MALE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASPERGILLUS ORYZAE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CASEINS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERTENSION; MALE; OLIGOPEPTIDES; SINGLE-BLIND METHOD;

ASPERGILLUS ORYZAE;

EID: 25444472353     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20051422     Document Type: Article

References (31)

1. Atkinson AB, Brown JI, Lever AF & Robertson JI (1980) Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet 2, 105-107.
2. Chalmers J, Macmahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C & Clark T (1999) World Health Organisation-International Society of Hypertension guidelines for the management of hypertension. Clinical and Experimental Hypertension 21, 1009-1060.
3. Conlin PR, Chow D, Miller ER 3rd, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM & Appel LJ (2000) The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertension 13, 949-955.
4. Ferguson RK, Vlasses PH, Koplin JR, Shirinian A, Burke JF Jr & Alexande JC (1980) Captopril in severe treatment-resistant hypertension. Am Heart J 99, 579-585.
5. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y & Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64, 767-771.
6. Kajimoto O, Aihara K, Hirata H, Takahashi R & Nakamura Y (2001) Hypertensive effects of the tablets containing 'Lactotripeptides (VPP, IPP)'. J Nutr Food (Japan) 4, 51-61.
7. Kawasaki T, Seki E, Osajima K, Yoshida M, Asada K, Matsui T & Osajima Y (2000) Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14, 519-523.
8. Maeno M, Yamamoto N & Takano T (1996) Identification of an antihypertensive peptide from casein hydrolyzate by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 79, 1316-1321.
9. Maruyama S, Nakagomi K, Tomizuka N & Suzuki H (1985) Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agric Biol Chem 49, 1405-1409.
10. Masuda O, Nakamura Y & Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126, 3063-3068.
11. Matsumura N, Fujii M, Takeda Y, Sugita K & Shimizu T (1993) Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 57, 695-697.
12. Matsuura K, Gotou T, Mizuno S, Nishimura S & Yamamoto N (2005) Quantitative analysis of antihypertensive peptides, Val-Pro-Pro and Ile-Pro-Pro, in casein hydrolyzate using an Aspergillus oryzae protease: an LC-MS method. Milchwissenschaft 60, 24-27.
13. Meisel H & Bockelmann W (1999) Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leewenhoek 76, 207-215.
14. Miyoshi S, Ishikawa H, Kaneko T, Fukui F, Tanaka H & Maruyama S (1991) Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agric Biol Chem 55, 1313-1318.
15. Mizuno S, Nishimura S, Matsuura K, Gotou T & Yamamoto N (2004) Release of short and proline rich antihypertensive peptides from casein hydrolyzate with an Aspergillus oryzae protease. J Dairy Sci 87, 3183-3188.
16. Moore TJ, Vollmer WM, Appel LJ, et al. (1999) Effect of dietary patters on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) trial: DASH collaborative research group. Hypertension 34, 472-477.
17. Nakamura Y, Kajimoto O, Kaneko K, Aihara K, Mizutani J, Ikeda N & Kajimoto Y (2002) Effect of the liquid yogurts containing 'lactotripeptide (VPP and IPP)' on high-normal blood pressure. J Nutr Food (Japan) 5, 55-66.
18. Nakamura Y, Masuda O & Takano T (1996) Decrease of tissue angiotensinI-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotech Biochem 60, 488-489.
19. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S & Takano T (1995a) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78, 777-783.
20. Nakamura Y, Yamamoto N, Sakai K & Takano T (1995b) Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 78, 1253-1257.
21. Seppo L, Jauhiainen T, Poussa T & Korpela R (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77, 326-330.
22. Seppo L, Kerojoki O, Suomalainen T & Korpela R (2002) The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension - a pilot study on humans. Milchwissenschaft 57, 124-127.
23. Staessen J (1981) The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin-angiotensin-aldosterone system. Clin Sci 61, 441-444.
24. Stornello M, Di Rao G, Iachello M, et al. (1983) Hemodynamic and humoral interactions between captopril and nifedipine. Hypertension 5, 154-156.
25. Svetkey LP, Moore TJ, Simons-Morton DG, et al. (2001) DASH collaborative research group Angiotensinogen genotype and blood pressure response in the dietary approaches to top hypertension (DASH) study. J Hypertens 19, 1949-1956.
26. Takano T (1998) Milk derived peptides and hypertension reduction. Int Dairy J 8, 375-381.
27. Yamamoto N, Akino A & Takano T (1994) Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotech Biochem 58, 776-778.
28. Yamamoto N, Ejiri M & Mizuno S (2003) Biogenic peptides and their potential use. Curr Pharmaceut Design 9, 1345-1355.
29. Yamamoto N & Takano T (1999) Antihypertensive peptides derived from milk proteins. Nahrung 43, 159-164.
30. Yamamoto N, Maeno M & Takano T (1999) Purification of the antihypertensive peptide from yogurt-like product. J Dairy Sci 82, 1388-1393.
31. Yokoyama K, Chiba H & Yoshikawa M (1992) Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci Biotechnol Biochem 56, 1541-1545.